On optimal delivery of combination therapy for tumors
From MaRDI portal
Publication:1042733
DOI10.1016/j.mbs.2009.08.004zbMath1176.92033OpenAlexW2091513278WikidataQ51798408 ScholiaQ51798408MaRDI QIDQ1042733
Heinz Schättler, Helmut Maurer, Alberto d'Onofrio, Urszula Łedzewicz-Kowalewska
Publication date: 7 December 2009
Published in: Mathematical Biosciences (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.mbs.2009.08.004
Applications of optimal control and differential games (49N90) Medical applications (general) (92C50) Existence theories for optimal control problems involving ordinary differential equations (49J15)
Related Items
Dynamical properties of a minimally parameterized mathematical model for metronomic chemotherapy ⋮ The stability analysis of tumor-immune responses to chemotherapy system driven by Gaussian colored noises ⋮ Optimal control of vibration-based micro-energy harvesters ⋮ Noise and delay enhanced stability in tumor-immune responses to chemotherapy system ⋮ Dynamics and optimal control of chemotherapy for low grade gliomas: insights from a mathematical model ⋮ A deterministic and stochastic model for the system dynamics of tumor-immune responses to chemotherapy ⋮ Dynamical analysis of chemotherapy models with time-dependent infusion ⋮ Local controllability and optimal control for a model of combined anticancer therapy with control delays ⋮ Optimal Control of Cancer Treatments: Mathematical Models for the Tumor Microenvironment ⋮ Control strategies for a tumor-immune system with impulsive drug delivery under a random environment ⋮ Optimal control of cancer chemotherapy with delays and state constraints ⋮ Optimal chemotherapy schedules from tumor entropy ⋮ Spreading speeds for a two-species competition-diffusion system ⋮ Sensitivity of combined chemo- and antiangiogenic therapy results in different models describing cancer growth ⋮ Mathematical modeling of the immune-chemotherapeutic treatment of breast cancer under some control parameters ⋮ An optimal control problem of immuno-chemotherapy in presence of gene therapy ⋮ Optimization of combined leukemia therapy by finite-dimensional optimal control modeling ⋮ Mathematical modelling for spatial optimization of irradiation during proton radiotherapy with nanosensitizers ⋮ The nature of Hopf bifurcation for the Gompertz model with delays ⋮ Structural stability investigation of bang-singular-bang optimal controls ⋮ Multi-input optimal control problems for combined tumor anti-angiogenic and radiotherapy treatments ⋮ Analysis of the Hopf bifurcation for the family of angiogenesis models. II: The case of two nonzero unequal delays ⋮ Combination of antiangiogenic treatment with chemotherapy as a multi‐input optimal control problem ⋮ Optimal control for selected cancer chemotherapy ODE models: a view on the potential of optimal schedules and choice of objective function ⋮ Stability analysis of the family of tumour angiogenesis models with distributed time delays ⋮ Multi-control commercial aircraft trajectory optimization in a vertical plane with state-inequality constraints via singular control theory ⋮ On strategies on a mathematical model for leukemia therapy ⋮ Optimal control problems for differential equations applied to tumor growth: state of the art ⋮ Stability analysis on a hybrid PDE–ODE system describing intermittent hormonal therapy of prostate cancer ⋮ Tumour growth control: analysis of alternative approaches ⋮ Optimizing the delivery of combination therapy for tumors: A mathematical model ⋮ Closed-loop control of tumor growth by means of anti-angiogenic administration ⋮ Chemotherapy of vascularised tumours: role of vessel density and the effect of vascular ``pruning ⋮ Delay Differential Equations in Bio-Populations ⋮ A survey of optimization models on cancer chemotherapy treatment planning ⋮ Catalog of the optimal controls in cancer chemotherapy for the Gompertz model depending on PK/PD and the integral constraint ⋮ Optimal combined radio- and anti-angiogenic cancer therapy ⋮ Optimal response to chemotherapy for a mathematical model of tumor-immune dynamics ⋮ Passing to the limit 2D–1D in a model for metastatic growth ⋮ Analysis of the effectiveness of the treatment of solid tumors in two cases of drug administration ⋮ Optimal control for a mathematical model of glioma treatment with oncolytic therapy and TNF-\(\alpha \) inhibitors ⋮ Optimization of additive chemotherapy combinations for an in vitro cell cycle model with constant drug exposures ⋮ Maximization of viability time in a mathematical model of cancer therapy ⋮ Stochastic modelling of slow-progressing tumors: analysis and applications to the cell interplay and control of low grade gliomas ⋮ A generalization of Gompertz law compatible with the Gyllenberg-Webb theory for tumour growth ⋮ Analysis of the Hopf bifurcation for the family of angiogenesis models ⋮ Optimization of an \textit{in vitro} chemotherapy to avoid resistant tumours ⋮ On the role of the objective in the optimization of compartmental models for biomedical therapies ⋮ On the role of pharmacometrics in mathematical models for cancer treatments ⋮ Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers ⋮ Combined therapy for treating solid tumors with chemotherapy and angiogenic inhibitors ⋮ On probabilistic certification of combined cancer therapies using strongly uncertain models ⋮ Optimisation of Cancer Drug Treatments Using Cell Population Dynamics ⋮ Tumor Development Under Combination Treatments with Anti-angiogenic Therapies ⋮ Therapy strategy in tumour cells and immune system interaction mathematical model ⋮ Qualitative analysis of tumor growth model under antiangiogenic therapy - choosing the effective operating point and design parameters for controller design ⋮ Optimal control for a mathematical model for chemotherapy with pharmacometrics ⋮ Effect of treatment on the global dynamics of delayed pathological angiogenesis models ⋮ Analyzing the quality robustness of chemotherapy plans with respect to model uncertainties ⋮ On the preliminary design of hyperthermia treatments based on infusion and heating of magnetic nanofluids ⋮ Unnamed Item
Cites Work
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Optimal scheduling of radiotherapy and angiogenic inhibitors
- Optimal control in a model of dendritic cell transfection cancer immunotherapy
- Critical-point analysis for three-variable cancer angiogenesis models
- Tutorials in mathematical biosciences III. Cell cycle, prolifereation, and cancer.
- Scheduling of angiogenic inhibitors for Gompertzian and logistic tumor growth models
- The response to antiangiogenic anticancer drugs that inhibit endothelial cell proliferation
- Multiscale modelling of tumour growth and therapy: the influence of vessel normalisation on chemotherapy
- Role of optimal control theory in cancer chemotherapy
- Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemo\-therapy
- Stochastic modelling of tumour-induced angiogenesis
- On the optimality of singular controls for a class of mathematical models for tumor anti-angiogenesis
- Continuous and discrete mathematical models of tumor-induced angiogenesis
- Optimal control of the chemotherapy of HIV
- SQP-methods for solving optimal control problems with control and state constraints: Adjoint variables, sensitivity analysis and real-time control
- Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis
- Singular trajectories and their role in control theory
- Optimal bang-bang controls for a two-compartment model in cancer chemotherapy
- Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999)
- Vascular network remodeling via vessel cooption, regression and growth in tumors
- A bi-parametric model for the tumour angiogenesis and antiangiogenesis therapy
- Modelling the role of angiogenesis and vasculogenesis in solid tumour growth
- A general framework for modeling tumor-immune system competition and immunotherapy: Mathematical analysis and biomedical inferences
- A Mathematical Tumor Model with Immune Resistance and Drug Therapy: An Optimal Control Approach
- AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem
- Realizable protocols for optimal administration of drugs in mathematical models for anti-angiogenic treatment
- A family of models of angiogenesis and anti-angiogenesis anti-cancer therapy
- Optimal Control Applied to Cell-Cycle-Specific Cancer Chemotherapy
- ANALYSIS OF A CELL-CYCLE SPECIFIC MODEL FOR CANCER CHEMOTHERAPY
- Simple ODE models of tumor growth and anti-angiogenic or radiation treatment
